7,649
Participants
Start Date
September 18, 2024
Primary Completion Date
September 1, 2026
Study Completion Date
September 1, 2026
Continuing Medical Education Events (CME)
An engaging 1-hour informational session focusing on topic areas such as implicit bias and emerging evidence from recent cancer clinical trials with CME credit or American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points available.
Trial Connect Portal
A digital tool to help facilitate rapid referral of patients to clinical trial opportunities at Moffitt.
Clinical Trial Newsletters
Electronic/paper newsletters to highlight open trials at Moffitt that will be distributed by email/mail.
Implicit Bias Training
A one-hour educational module will cover information on implicit bias to support the recruitment of diverse patients.
Recruitment Dashboard
A dynamic dashboard depicting the number of patients recruited to clinical trials by gender, race, ethnicity, age, cancer type, residence in the catchment area, and other key clinical characteristics.
Portfolio Profiler
An interactive dashboard to allow cancer center physicians easily identify gaps in the current clinical trial portfolio that may be contributing to racial/ethnic disparities in trial enrollment.
Eligibility Calculator
A digital calculator that will allow for assessment of the potential impact of clinical trial eligibility criteria (e.g., comorbidities, age, lab values) that may disproportionately exclude patients who are Black and Hispanic prior to submission of clinical trial protocols to the Scientific Review Committee.
Clinical Trial Education Sessions (Community Residents Only)
An engaging 1-hour educational session delivered by a community health educator that includes basic information about clinical trials, their importance, myths, need for diversity in the trials process, and resources for finding more information about clinical trials.
ACT WONDER²S Phone-line/Email (Community Residents and Moffitt Patients)
A study team member will be available for questions via a dedicated phone-line and email for community residents and Moffitt patients with a return contact within 24-hours.
New Patient Information (Moffitt Patients Only)
Including CHOICES DA, a web-based tool to improve multiple aspects of decision-making related to participation in cancer clinical trials.
No Intervention
Control group with no intervention.
RECRUITING
Moffitt Cancer Center, Tampa
National Cancer Institute (NCI)
NIH
H. Lee Moffitt Cancer Center and Research Institute
OTHER